MEMBERSHIP INTEREST EXCHANGE AND ASSET SALE AGREEMENTMembership Interest Exchange and Asset Sale Agreement • May 23rd, 2005 • A.C.T. Holdings, Inc. • Pharmaceutical preparations • Massachusetts
This Membership Interest Exchange and Asset Sale Agreement, dated as of the 31st day of May, 2000, is by and among ADVANCED CELL TECHNOLOGY; INC. (“ACT”), a Delaware corporation, HEMATECH, LLC (“Hematech”), a Delaware limited liability company, CYAGRA, LLC (“Cyagra”), a Delaware limited liability company, CYAGRA OF KANSAS, LLC (“CK”), a Kansas limited liability company, THE BARTON FAMILY LIMITED PARTNERSHIP (“BFLP”), a Connecticut limited partnership, THE ROBL FAMILY LIMITED PARTNERSHIP (“RFLP”), a Connecticut limited partnership, WALTER M. FIEDEROWICZ (“Fiederowicz”), an individual residing in Connecticut, RICHARD GOLDSBY (“Goldsby”), an individual residing in Massachusetts, BARBARA OSBORNE (“Osborne”), an individual residing in Massachusetts, JAMES M. ROBL (“Robl”), an individual residing in Massachusetts, and JAMES BARTON (“Barton”), an individual residing in Connecticut, (BFLP, RFLP, Fiederowicz, Goldsby, and Osborne being hereinafter referred to as the “Cyagra Holders”).
